Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOPT: Rosiglitazone vs Metformin or Glyburide in T2DM
NCT00279045Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2000
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jan 2000; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00279045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00279045.